/PRNewswire/ Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing and.
- Annual Net Product Sales Across the Company Grew 25% to $107.7 million in 2022, Compared to Annual Net Product Sales in 2021 -
- APONVIE™ Commercially Launched on March 6, 2023 -
- ZYNRELEF® Net Product Sales for Fourth Quarter of 2022 .
Heron Therapeutics Highlights Progress in Acute Care and Oncology Care Franchises streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
GitLab vor Börsengang: Wahnsinnswachstum im Boom-Markt deraktionaer.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from deraktionaer.de Daily Mail and Mail on Sunday newspapers.
Der Sneaker-Hype: Von der Laufbahn auf den Laufsteg kurier.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kurier.at Daily Mail and Mail on Sunday newspapers.